JPS6029665A - Quantitive determination of antigen - Google Patents

Quantitive determination of antigen

Info

Publication number
JPS6029665A
JPS6029665A JP13748583A JP13748583A JPS6029665A JP S6029665 A JPS6029665 A JP S6029665A JP 13748583 A JP13748583 A JP 13748583A JP 13748583 A JP13748583 A JP 13748583A JP S6029665 A JPS6029665 A JP S6029665A
Authority
JP
Japan
Prior art keywords
antigen
red blood
protein
blood cells
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13748583A
Other languages
Japanese (ja)
Inventor
Shosaku Motoda
昭策 元田
Shigeru Sekine
盛 関根
Satoru Imai
悟 今井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denka Seiken Co Ltd
Original Assignee
Denka Seiken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denka Seiken Co Ltd filed Critical Denka Seiken Co Ltd
Priority to JP13748583A priority Critical patent/JPS6029665A/en
Publication of JPS6029665A publication Critical patent/JPS6029665A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555Red blood cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PURPOSE:To enable easy and quick quantitative determination of an antigen with good sensitivity by adding an antibody for the antigen to a red blood cell suspension in which protein A is bonded with the red blood cells then adding further the antigen and complement thereto and bringing said liquid into reaction. CONSTITUTION:This method consists of bringing the antigen to be quantitatively determined and an antibody into reaction directly on the surface of red blood cells and determining quantatively and indirectly the antigen from the hemolysis of the red blood cells by the bonding reaction of the complement. The protein A is usually obtd. by refining the same from a yellowish staphylococcus. The sensitized red blood cells bond the protein A. The kind of the antigen is enumerated by, for example, alpha-fetoprotein, ferritin, C-reactive protein, HB, immune globulin G, immune globulin M, myoglobin, etc. It is preferable to adsorb chemically the protein A to the red blood cells in the case of bonding the protein A to the red blood cells. The antigen is determined quantitively with high sensitivity by increasing the amt. of the protein A to be sensitized.

Description

【発明の詳細な説明】 本発明は衆1却、な抗原を定理する方pに関するもので
ある。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for theorem of antigens.

近年医療分野においては病気の診断等のため抗原等を高
い偏勅性をもって簡便迅速に定角することか極めて穿扱
な課題にガっている。
In recent years, in the medical field, it has become an extremely difficult problem to easily and quickly determine the angle of antigens with high polarization for the purpose of diagnosing diseases, etc.

従来免疫化学的測定法による抗原の定μ法としでは放射
化免疫測定法(ラジオイムノアッセイ)(4)、酸素免
疫測定法(B)、逆受身赤血球凝集反応法(CJ 、及
び−元放射状免疫拡散法の)等にょシ行われているが、
これらの定K方法は夫々次の如き次点を有するものであ
った。
Conventional immunochemical assays for antigen determination include activation immunoassay (radioimmunoassay) (4), oxygen immunoassay (B), reverse passive hemagglutination (CJ), and radial immunodiffusion. law) etc. are being carried out,
Each of these constant K methods had the following runner-up points.

A方法: 洗浄操作を必男とし、またラジメアイソトー
プを旬月するため特別]の 設備を必要とする等莫大な設備費と 繁穎な手数を璧する。
Method A: Requires cleaning operations, and requires special equipment to remove radioisotopes, resulting in huge equipment costs and time-consuming procedures.

B方法ニー船齢に洗浄の操作を必扱とし且つ判定までに
長時間を要する。
Method B requires a cleaning operation depending on the age of the ship and takes a long time to make a determination.

C方〃−: ダイリーーターにて試刺を2倍に階段希釈
する操作及びドロッパーに て希釈液等を滴下1゛る操作を心裏と ブるため繁雑な千Fを批する。又判 定までに長時間す少すると共に抗原 量を2倍階段希釈の終末佃で判定す るため雑駁な判定になるおそわがあ る。
Method C: We criticize the complicated 1,000-F method in order to make it difficult to understand the operation of stepwise diluting the test piece to 2 times with a dilator and the operation of dropping diluted liquid etc. once with a dropper. In addition, it takes a long time to make a determination, and since the antigen amount is determined at the end of a 2-fold serial dilution, the determination may be inaccurate.

D方法二 判定までに多大な時間を袈すると共に感度的
に不十分である。
D Method 2 It takes a lot of time to make a determination and is insufficient in terms of sensitivity.

本発明はかかる欠点を改善せんとして銃声研究を行った
fFA果、感度よ< Lかも簡便迅速に抗原を定量づる
方法を見出したものである。即ち本発明方法はプロティ
ンAが免疫グロブリンGと結合する4<I勿乏利用し、
赤J(r+球にプロティンAをh〜合させた赤血球浮遊
液に、定量ぜんとする抗原に対うる抗体乞添加した後、
さらに抗原と補体とを添加して尺応ゼしめることにより
赤血球を溶血さ七、計溶血現象から間接的に抗原を定損
する方法である。
The present invention is based on the results of fFA research conducted on gunshot sounds in an attempt to improve these drawbacks, and the discovery of a simple and rapid method for quantifying antigens with sensitivity <L. That is, the method of the present invention makes use of protein A binding to immunoglobulin G,
After adding a quantitative amount of an antibody against the antigen to a red blood cell suspension containing red J(r+ cells and protein A),
Furthermore, the red blood cells are hemolyzed by adding antigen and complement to make them sizable, thereby indirectly depleting the antigen from the total hemolytic phenomenon.

本発明方法において、プロティンAとは通常黄金ブドウ
球菌かられ1製して得たものである。
In the method of the present invention, protein A is usually obtained from Staphylococcus aureus.

又本発明1方法において駿f1赤」角球妹)90デイン
Aを結合はせるもので47・9、このプ゛ロチインAi
l免疫クロプリンGと詳、台ゴる性衆があるため、多く
の117iガ・の抗原定匍に汎用性があシ、抗原の種類
として鉱、例えけα−フェトゾロティン、フェリチン、
C−戊応jI!J蛋白、HB、免疫クロンリンG、免疫
グロン゛リンM、ミオグロビンなどをおりることかでき
る。然しこれらの抗原に固定ネれるものではなく抗原抗
体反応に補イ4か開力する1べてのオψ類の抗原を足部
することかできる。
In addition, in method 1 of the present invention, 47.9 is used to bind 90 dein A, and this protein Ai
Since there is a large number of people who are immune to clopurin G, many 117i moth antigens are versatile, and the types of antigens include minerals, such as α-fetozolotin, ferritin,
C-JI! It can absorb J protein, HB, immunoglobin G, immunoglobin M, myoglobin, etc. However, rather than being fixed to these antigens, it is possible to use all types of antigens that complement the antigen-antibody reaction.

本発明方法において赤血球にプロティンAを結合さゼる
場合、赤血球に化学的に睦ルさせるのがグIましい。赤
血球に抗体等の蛋白外を川持さゼる1泄にうでに多くの
方汐か祈多されている。例えはタンニン酸、塙化クロム
、7J5溶作カルボジイミド等による方法で42・る。
When protein A is bound to red blood cells in the method of the present invention, it is preferable to bind the red blood cells chemically. Many people have been praying for the secretion of proteins such as antibodies into the red blood cells. For example, 42.

本発明方法において感作するプロティンAの隼は抗原の
定豫感度に影響を及はずものであり、感作するプロティ
ンAの穿な多くうることによって高感度にて抗原を定し
゛することがてきる。
In the method of the present invention, the presence of protein A that sensitizes should not affect the sensitivity of antigen determination, and the presence of a large amount of sensitizing protein A makes it possible to identify antigens with high sensitivity. Ru.

例えは赤血球]、X1010個に約し、プロティン02
〜5rtryjrc添力1)シて結合ブることか望まし
い。
For example, red blood cells], approximately equal to 1010 cells, protein 02
~5rtryjrc addition 1) It is desirable to use the combination function.

なお赤血球は限定さ11るものでb、なく如何なるわ」
類の赤血球でもよい。し力し短筒のK、度を高めるため
には補体結合反応による溶血現象が斗じやすい赤血球、
例えは羊赤血球等かな1貫しい。
Furthermore, red blood cells are limited, so what would happen without them?
Red blood cells of the same type may also be used. In order to increase the strength and short-tubular K, red blood cells that are prone to hemolysis due to complement fixation reaction,
A good example would be sheep red blood cells.

又補体の種類は、特に限定されるもので幻なく補体活性
の高い袖体が望甘しく、例えはモルモット袖体等である
Furthermore, the type of complement is not particularly limited, and a sleeve with a high complement activity is desirable, such as a guinea pig sleeve.

而して本発明方法と従来の袖体結合反応試験とはどのよ
うに異るのかについて説明する。
Now, how the method of the present invention differs from the conventional sleeve binding reaction test will be explained.

袖体結合反応試験は抗原定−h:法或は抗体定量法とし
て従来〃・ら知られている方法である。即ち抗原に抗体
が結−@すると抗体分子に分−F亥容がおこり抗体に袖
体が結合し活性化消費される。これを補体結合反応とい
う。この反応を利用し消費された補体iから間接的に抗
原抗体反応の強さを知ることが出芽る。例えは抗原量を
一定にしておけは抗体牙を、抗体方:f6:−足にして
ふりは抗原量を測定することができる。抗原抗体反応に
よる袖体の消費は羊赤血球に効する抗体か結合した羊赤
血球の溶血を指標とする。従来の袖体結合反応試験では
、このような抗原抗体反応に泊費芒れたムリの袖体によ
る羊赤n’+・球に対づる抗体か糾1合した羊赤血球の
溶血から抗原或は抗体を定量するものである。然し本発
明方法は@按摩血球の表面で元弁ぜんとする抗原と抗体
を反応格上、補体結合反応による赤血球の溶血現象から
間接的に抗原を定11るものである。
The sleeve binding reaction test is a method conventionally known as an antigen determination method or an antibody determination method. In other words, when an antibody binds to an antigen, the antibody molecule undergoes a -F induction, and the sleeves bind to the antibody and are activated and consumed. This is called the complement fixation reaction. Utilizing this reaction, it is now possible to indirectly determine the strength of the antigen-antibody reaction from the consumed complement i. For example, if the amount of antigen is kept constant, the amount of antigen can be measured by using the antibody fang as the antibody side, and using the antibody side as f6:-foot. Consumption of the sleeve due to antigen-antibody reaction is an indicator of hemolysis of sheep red blood cells bound to antibodies that are effective against sheep red blood cells. In the conventional sleeve binding reaction test, it is difficult to conduct such an antigen-antibody reaction, and the antibody against the sheep's red n'+ cells is detected by the sleeve. This is for quantifying antibodies. However, in the method of the present invention, the antigen is indirectly determined from the hemolysis of red blood cells caused by the complement fixation reaction, by reacting the original antigen with the antibody on the surface of the massaged blood cells.

従来の袖体結合反応試験でに抗原抗体反応にともなって
消臀された外ルの補体による羊赤血球に対する抗体が結
合した羊赤血球の溶血を指標さするため補体奔が一定で
なりil、は々らず、被検血清中の既存の袖体の影p#
乏なくすだめに56℃、30分間非動化を行わ々りれは
々ら々い。
In the conventional sleeve binding reaction test, the hemolysis of sheep erythrocytes to which antibodies against sheep erythrocytes have bound due to the external complement extinguished by the antigen-antibody reaction is used as an indicator, so the amount of complement remains constant. The shadow of the existing body in the test serum p#
In order to avoid waste, immobilization was performed at 56°C for 30 minutes.

そのため熱に不安定な抗原には辺・用することが出来な
かった。然し本発明方法において桿補体は一定以上であ
れはよく被検血清中の既存の補体の影響がなく非動化を
做−1:!う熱に不安定な抗原でもだ月−プることか比
法る。更に従来の補体結合反応試験では被検血栖奮2倍
階段希釈−するなどの繁雑な技作を必黴とし且つ判定ま
てに長時間を扱するか、本発明方法においでは2倍階段
煽釈などの操作奮必扱とゼ″′j簡俊・迅速に抗原を定
量するこ七ができる。
Therefore, it could not be used for antigens that are unstable to heat. However, in the method of the present invention, if rod complement is above a certain level, the existing complement in the test serum will not be affected and will be immobilized. Antigens that are unstable to fever may also be used. Furthermore, conventional complement fixation reaction tests require complicated techniques such as 2-fold serial dilution of the blood sample to be tested and require a long period of time before making a determination; It is possible to easily and quickly quantify the antigen without having to deal with operations such as excitation.

次に本発明の実施例についてi(,1明ブる。Next, regarding the embodiment of the present invention, i(, 1 bright).

実施例(1) 生理食塩液にて洗浄し、た羊赤血球沈査1容に坊化クロ
ム((14ml/7 ml) 2 馬と70ロチインA
(2,5m?/ηze、ファルマシアファインクミカル
メ+lJ!! )2容とを#7台し?渦にで30多J 
li4 &一応さゼた後、仕3.!I’:食」4.・液
にて洗浄し8%の浮遊にとした。とのフ0ロチインA感
イ′1羊赤血球rX′遊液50/llに抗ヒlα−フェ
トグロラインウーリギ抗体50μlを訟;加しカニf表
、第1図に示す如き8二々の濃度のヒトα−フェトン6
0ティン届ヲ名むKI℃木I50 itlを路8力11
シ、頁にへra )−−ル5Ji lil液pIl 7
.2 i+c ’T−100佑C(希釈したモル〜しソ
ト袖体3. (l mlをな・加し、37℃+ 303
j間&応ヲ0ッ7’iC後、a−k Eh i rcj
t’j1’r VL X。
Example (1) Washed with physiological saline and added 1 volume of sheep erythrocyte sediment to 1 volume of chromium botanicals ((14 ml/7 ml)) and 70 lotiine A.
(2.5m?/ηze, Pharmacia Fine Kumikarume + lJ!!) 2 units and #7? 30 J in the whirlpool
li4 & After a while, work 3. ! I': Food" 4. - Washed with liquid to make it 8% floating. To 50 μl of sheep red blood cell rX fluid was added 50 μl of anti-hill α-fetogloline woolly antibody to 50 μl of the sheep red blood cell rX fluid, and 8 ml of fluorine A as shown in Table 1 and Figure 1 was added. Concentration of human alpha-phetone 6
0 tin delivery name KI℃ tree I50 itl ro 8 force 11
shi, page to ra)--le 5 Ji lil liquid pIl 7
.. 2 i+c'T-100C (diluted mol ~ 3. (l ml), 37℃ + 303
After j time & response 7'iC, a-k Eh i rcj
t'j1'r VL X.

っで上澄Cヘモクロピンのψ′、光度(41bmm)を
夫々沖」定した。
The ψ' and luminosity (41 bmm) of the supernatant C hemocropin were determined.

そのに:、 4+:は札1−にボす通りでぐ・シ、ヒト
α−フェトプロラインの温度とll!!、光度とC泊線
関イガ(′・3よっ1ヒトα−フェトプロブインを26
することができた。
Also:, 4+: The temperature of human α-fetoproline and ll! ! , Luminosity and C Tomari line Sekiiga (′・3 1 human α-fetoprobuin 26
We were able to.

実施例(2) 実M1・例(])と同様K 1Lll’A I、たプロ
ラインA沿作羊赤JrII FJi浮i’ij ?l+
 5 (1piに抗HBgつ1 キ抗体(200μ5L
/III/)50μl’f:添加した後、第2図に示す
如き程々の濃度のHB 抗原を含む試料50μlを添加
し、更にペロチール緩衝液にて1004T<に希釈した
モルモット袖体3. Q mlを添加し、37℃。
Example (2) Actual M1 - Same as example (]) K 1Lll'A I, Proline A along sheep red JrII FJi floating i'ij? l+
5 (anti-HBg antibody (200μ5L for 1pi)
/III/) 50 μl'f: After addition, 50 μl of a sample containing a moderate concentration of HB antigen as shown in FIG. 2 was added, and the guinea pig cuff 3. Add Q ml and heat at 37°C.

30分間反応させた彷、低速度遠心操作によって上澄の
へモクロビンの@光度(416九m)を夫々測定した。
After 30 minutes of reaction, the luminous intensity (4169 m) of hemoglobin in the supernatant was measured by low-speed centrifugation.

その結果は第2図に示す通シてあシ、逆受携赤血球凝集
反応法(R−PHA法〕によりめた)IB 抗原濃度と
吸光度との旧線IPl係によってHB 抗原を定豫する
ことかできた。
The results are shown in Figure 2.The HB antigen was determined by the reverse passivation hemagglutination method (R-PHA method). I was able to do it.

実施例(3) 実施例(1)と同様に訴、製したプロティンA感作羊赤
血球浮遊液50μlに抗ヒト免疫グロフリンG(γ鎖判
異性)ウツギ抗体(200μy/ゴ)50μlを添加し
た後第3図に示す如き利1々の濃度のヒト免疫グロブリ
ンGを含む試料50μlを添加し、更にペロチール緩衝
液に1100倍に希釈したモルモット補体3. (l 
mlを添加し、37℃30分間反応させた後、低速遠心
操作によって上澄のヘモクロビンの吸光度(41611
11)’i測足した。
Example (3) After adding 50 μl of anti-human immunoglobulin G (γ chain discriminating) rabbit antibody (200 μy/g) to 50 μl of protein A-sensitized sheep red blood cell suspension prepared in the same manner as in Example (1). 50 μl of samples containing human immunoglobulin G at various concentrations as shown in FIG. 3 were added, and guinea pig complement 3. (l
ml and reacted for 30 minutes at 37°C, the absorbance of hemoglobin (41611
11) 'i was measured.

イの結果り第3図に示1”通りでをシ、ヒト免疫り゛ロ
ブリンGの濃度と吸光度との面線関係によっ1ヒト免疫
り゛ロブリンGを定h1う゛ることができた。
As a result of step 1, as shown in FIG. 3, it was possible to determine the amount of human immunoglobulin G based on the surface line relationship between the concentration of human immunoglobulin G and the absorbance.

以上前述し、だ如くオ殉り1力〃−によりn優わた感度
含有し十1つ介いω迅返に抗原′jL定損うることかで
きると共に多椋類の抗原に通用しうるキrN+著な効・
牙を不する。
As mentioned above, it is possible to quickly deplete the antigen 'jL through the 11-mediated method, which contains excellent sensitivity and is effective against many types of antigens. Significant effect
lose one's fangs.

【図面の簡単な説明】[Brief explanation of drawings]

し】面は本発明抗原足分力汐、において名わの抗原と吸
ブ(4度との関係を示うものてあシ、第1図り、ヒトα
−フェトプロラインの濃度と吸光度との関僧Ni1Si
lす1図、第2図位HB 抗原の濃度と吸光度との関係
IIt、明図、第3図ね、ヒト免疫グロブリンGの濃度
と吸ブC度との門係肢明図である。 B’清+1人代灯人 方理士 鈴 江 武 彦特許庁長
官 若 杉 和 夫 膜 抗原定量方法 5、自発補正 6 補正の対象 明細書 7、補正の内容 (1)明細書第1頁第19行において「酸素免疫測定法
(B)、Jとあるな「酵素免疫測定法(B)、Jと訂正
する。 +21 q % 4頁第12行において「プロティン」
とあるを「ブイティンA」と訂正する。 (3) 同第5頁第12行において「抗原抗体反応とあ
るを「抗原抗体反応」と訂正する。 (4) 同第7頁第12行、第8頁@6行及び第9頁第
1行において夫々「ヘモクロビン」とあるな「ヘモグロ
ビン」と訂正する。
] The surface shows the relationship between the antigen of the present invention and the absorption (4 degrees), the first figure, human α
- Ni1Si, the relationship between the concentration and absorbance of Fetoproline
Figure 1, Figure 2 shows the relationship between the concentration of HB antigen and absorbance, and Figure 3 shows the relationship between the concentration of human immunoglobulin G and absorbance. B'Kiyoshi + 1 person as a littoral engineer Takehiko Suzue Director General of the Patent Office Kazuo Wakasugi Membrane antigen quantification method 5, voluntary amendment 6 Specification subject to amendment 7, content of amendment (1) Specification page 1, No. 19 In the line "Oxygen immunoassay (B), J", correct it as "Enzyme immunoassay (B), J." +21 q % In line 12 of page 4, "Protein"
Correct the statement to read "Buitin A." (3) On page 5, line 12, "antigen-antibody reaction" is corrected to "antigen-antibody reaction." (4) On page 7, line 12, page 8, line 6, and page 9, line 1, the words "hemoclobin" are corrected to "hemoglobin."

Claims (1)

【特許請求の範囲】[Claims] 赤血球にプロディンAを結合させた赤抑球浮遊液に、t
 倒せんとする抗原に対する抗体を添加した後、さらに
抗原と補体とを添加して反応せしめて赤血球を溶血させ
、該溶崩現象から間接的に抗坤を定預することを勃徴と
する抗原量l方法。
To the erythrocyte suspension containing prodin A bound to red blood cells, t
After adding an antibody against the antigen to be defeated, the antigen and complement are further added to cause a reaction, causing hemolysis of the red blood cells, and this dissolution phenomenon indirectly leads to an erection. Antigen amount l method.
JP13748583A 1983-07-29 1983-07-29 Quantitive determination of antigen Pending JPS6029665A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13748583A JPS6029665A (en) 1983-07-29 1983-07-29 Quantitive determination of antigen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13748583A JPS6029665A (en) 1983-07-29 1983-07-29 Quantitive determination of antigen

Publications (1)

Publication Number Publication Date
JPS6029665A true JPS6029665A (en) 1985-02-15

Family

ID=15199735

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13748583A Pending JPS6029665A (en) 1983-07-29 1983-07-29 Quantitive determination of antigen

Country Status (1)

Country Link
JP (1) JPS6029665A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03100466A (en) * 1989-09-13 1991-04-25 Agency Of Ind Science & Technol Chemical amplification type chemical emission immunoassay

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03100466A (en) * 1989-09-13 1991-04-25 Agency Of Ind Science & Technol Chemical amplification type chemical emission immunoassay

Similar Documents

Publication Publication Date Title
CN102628865B (en) Latex enhanced immunoturbidimetry kit for detection of myoglobin content
Fielding et al. Enzyme immunoassay for urinary albumin.
Panush et al. Serum and synovial fluid IgG, IgA and IgM antigammaglobulins in rheumatoid arthritis
DK153589B (en) LATEX REAGENT FOR THE DETECTION AND DETERMINATION OF ANTIBODIES OR ANTIGANTS, A DIAGNOSTIC AGENT CONTAINING THE REAGENT, A PROCEDURE FOR PREPARING THIS REAGENT OR PROCEDURE FOR DETERMINING OR ORDERING
JPH0765998B2 (en) Assay method and assay reagent for specifically binding substances
Viberti et al. Detection of potentially reversible diabetic albuminuria: a three-drop agglutination test for urinary albumin at low concentration
US4539292A (en) Immunoassay technique for specific immunoglobulin E
JPS58165055A (en) Method of immunologically coagulating latex
Kallerup et al. Igg-, igm-and iga-rheumatoid factors in healthy adults and rheumatoid patients determined by an indirect immunofluoroscence method
US4624927A (en) Reagent for determination of blood coagulation factor XIII
JPH04248465A (en) Immuno-sedimentation method for measuring connectable analite, and reagent for executing said method
JPS6029665A (en) Quantitive determination of antigen
JP2682697B2 (en) Immunoassay reagents and immunoassays
AU657595B2 (en) A method for the determination of antigens or antibodies in the presence of an immune complex
Karsh et al. Quantitative determination of rheumatoid factor by an enzyme-labeled immunoassay
CN108918888A (en) It is a kind of detect Endostatin latex enhancing immune than turbid kit and its application
CN103706340A (en) Waterborne adhesive chromatography media and method of using waterborne adhesive chromatography media for detection
EP0485377B1 (en) Solid phase immuno-assay with labelled conjugate
JP2004012434A (en) Method for measuring pepsinogen and measuring kit
JPS59102161A (en) Antigen detection reagent by anti-passive agglutination
JP2002214236A (en) Method and device for detecting antigen in blood
JPS59136657A (en) Reagent for measuring eighth factor of blood clotting
EP0132537A1 (en) Immunoassay
JPS60363A (en) Novel method for quantitative determination of antigen
Keyser et al. Standardization of immunochemical determinations of serum albumin.